Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Liverpool, New York 13088


The aim of this feasibility study is to provide data for a subsequent randomized controlled trial to investigate if patient outcomes will be improved after an acute COPD exacerbation using domiciliary nasal high flow therapy (NHF) compared to standard care. This feasibility study will investigate the following: process, resources, management and scientific aspects of delivering NHF as an adjunct therapy in COPD patients.


Inclusion Criteria: - 18 years of age or older - Male and female - Admitted to the respiratory ward(s) of either recruiting hospitals with AECOPD as the primary diagnostic reason for admission. Exclusion Criteria: - Given a new home oxygen therapy prescription during the current hospital admission - The investigator believes the participant or their care giver will be unable to safely use the myAIRVO 2 device following discharge - They have any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results



Primary Contact:

Principal Investigator
James Fingleton, MBChB
Medical Research Institute of New Zealand

Backup Contact:


Location Contact:

Liverpool, New York 13088
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.